Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid malignant tumors.

A new study using NHANES data (1999–2018) finds that novel inflammatory markers, including AISI, SIRI, and SII, are strongly linked to osteoporosis risk in elderly patients. These biomarkers may help ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is providing this bi-weekly update ...

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...

Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the ...

The immune system, made up of cells, tissues, and organs, protects against illnesses. It has innate and acquired immunity.

For the first time, researchers outline new therapeutic avenues for a rare patient group with unmet clinical needs, paving ...

A new systemic nutrition-inflammation index predicted perioperative non-small cell lung cancer outcomes better than current ...

The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide's ...

Iovance Biotherapeutics plans to add hundreds of new jobs at the Navy Yard in South Philadelphia as part of an effort to ramp ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...